ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 49 • 2012 ACR/ARHP Annual Meeting

    The Spatial Energy Expenditure Configuration and Possible Applications in an Experimental Model of Arthritis

    Susanne Klatt1 and Rainer H. Straub2, 1Department of Internal Medicine I, Laboratory of Exp. Rheumatology and Neuroendocrine Immunology, University Hospital Regensburg, Regensburg, 93055, Germany, 2Department of Internal Medicine 1, University Hospital Regensburg, Regensburg, Germany

    Background/Purpose: An autoimmune response with differentiation and proliferation of immune cells and the subsequent tissue-directed inflammatory process in the symptomatic phase of the disease are…
  • Abstract Number: 50 • 2012 ACR/ARHP Annual Meeting

    Human Chondrocyte Dedifferentiation Is Accompagnied by CD105 Endoglin Expression, ALK-1/Smad1/5 Phosphorylation and Leptin Production – Stimulation by Prednisolone and Aldosterone Through the Glucocorticoid Receptor

    Olivier Malaise1, Biserka Relic2, Mustapha Zeddou1, Edith Charlier1, Florence Quesada Calvo1, Sophie Neuville3, Dominique de Seny2 and Michel G. Malaise4, 1Department of Rheumatology, GIGA Research - University of Liège - CHU Liège, Liège, Belgium, 2Department of Rheumatology, GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 3GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 4Department of Rheumatology, University of Liège - CHU Liège, Liège, Belgium

    Background/Purpose:   Leptin, mainly produced by the adipose tissue including fat neighboring the joint, is considered as pro-inflammatory in osteoarthritis (OA). Normal cartilage does not…
  • Abstract Number: 51 • 2012 ACR/ARHP Annual Meeting

    Phosphodiesterase 4 Expression in Rheumatoid Arthritis Synovium and Anti-Inflammatory Effects of Apremilast On Synovial Fibroblasts

    Lei Wu, Mary Adams, Stacey Parton and Peter Schafer, Department of Translational Development, Celgene Corporation, Summit, NJ

    Background/Purpose: Apremilast (APR), a small molecule specific inhibitor of phosphodiesterase 4 (PDE4), works intracellularly to modulate pro- and anti-inflammatory mediator production in both immune and…
  • Abstract Number: 52 • 2012 ACR/ARHP Annual Meeting

    The Validity of the Diagnosis Inflammatory Arthritis in Primary Care

    Markus M.J. Nielen1, Jennie Ursum1, François G. Schellevis2 and Joke C. Korevaar1, 1NIVEL (Netherlands Institute for Health Services Research), Utrecht, Netherlands, 2Department of General Practice and Elderly Care Medicine/EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, Netherlands

    Background/Purpose: Large population-based databases, such as electronic medical records (EMRs) from patients in primary care, are useful data sources to investigate morbidity and health care…
  • Abstract Number: 53 • 2012 ACR/ARHP Annual Meeting

    Comparison of Decision Rules for Identifying Patients with Rheumatoid Arthritis (RA) in Administrative Healthcare Databases

    John G. Hanly, Kara Thompson and Chris Skedgel, Division of Rheumatology, Dalhousie University and Capital Health, Halifax, NS, Canada

    Background/Purpose: Identification of RA cases in administrative healthcare databases is used to estimate disease frequency, healthcare utilization and cost for RA. However, the optimal methodology…
  • Abstract Number: 54 • 2012 ACR/ARHP Annual Meeting

    Use of Health Plan Data to Assess Feasibility of Large Pragmatic Clinical Trials in Rheumatoid Arthritis

    Jeffrey R. Curtis1, Lang Chen2, Fenglong Xie3, Jie Zhang1, Kenneth G. Saag4, Stacey Cofield5, Kevin L. Winthrop6, Nicole C. Wright7 and Elizabeth S. Delzell8, 1Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 4Div Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 5School of Public Health, Department of Biostatistics, Univ of Alabama at Birmingham,, Birmingham, AL, 6Dept of Infectious Disease, Oregon Health & Science University, Portland, OR, 7Epidemiology, The University of Alabama at Birmingham, Birmingham, AL, 8Epidemiology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Large pragmatic clinical trials (PCTs) are increasingly used to conduct comparative effectiveness research (CER). PCTs typically have simple inclusion/exclusion criteria and hard outcomes (e.g.…
  • Abstract Number: 55 • 2012 ACR/ARHP Annual Meeting

    Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Seen by Rheumatologists

    Jessica Widdifield1, Sasha Bernatsky2, J. Michael Paterson3, Karen Tu3, Ryan Ng3, J. Carter Thorne4, Janet E. Pope5 and Claire Bombardier6, 1University of Toronto, Toronto, ON, Canada, 2Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, 3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 4Southlake Regional Health Centre, Newmarket, ON, Canada, 5Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, 6Rheumatology, University of Toronto, Toronto, ON, Canada

    Background/Purpose: In a predominantly universal single-payer health system, Canadian health administrative data are a valuable tool and increasingly used for research. Few studies have rigorously…
  • Abstract Number: 56 • 2012 ACR/ARHP Annual Meeting

    A Validated Mathematical Model Using Electronic Health Records to Identify Rheumatoid Arthritis Patients for Observational Studies

    Aarat M. Patel1, Ilinca D. Metes2, Larry W. Moreland3, Melissa Saul4, Stephen R. Wisniewski5 and Marc C. Levesque6, 1Rheumatology & Clinical Immun / Pediatric Rheumatology, Univ of Pittsburgh Med Ctr / Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 2Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Pittsburgh, Pittsburgh, PA, 3Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 4Biomedical Informatics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, 5Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: To develop and validate a search algorithm with a high specificity and sensitivity to identify rheumatoid arthritis (RA) patients in a large health care…
  • Abstract Number: 57 • 2012 ACR/ARHP Annual Meeting

    A British Survey of Time to Presentation and Treatment of Rheumatoid Arthritis in Subjects of Black and Minority Ethnic Origin

    Sonia Panchal1, Ash Samanta1, Arumugam Moorthy1, Sawson Hayat2, Ira Pande2, Adewale O. Adebajo3 and Kuntal Chakravarty4, 1Rheumatology, University Hospitals of Leicester, Leicester, United Kingdom, 2Rheumatology, Nottingham University Hospitals, Nottingham, United Kingdom, 3Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom, 4Dept of Rheumatology, University of Bedfordshire Post Graduate Medical School, Romford, United Kingdom

    Background/Purpose: National guidelines mandate urgent referral of rheumatoid arthritis (RA) for specialist treatment if more than three months from symptom onset; initial combination therapy with…
  • Abstract Number: 58 • 2012 ACR/ARHP Annual Meeting

    5 Million Patients and Not 0.34% Is Worrisome: Burden of Rheumatoid Arthritis in India Based On a Bone and Joint Decade India Community Oriented Program for Control of Rheumatic Disease

    Arvind Chopra1, R. Ghorpade2, S. Sarmukkadam3, VL Joshi1, AJ. Mathews4, L. Gauri5, A. Rahim6, K. Datta7, S. Chaturvedi8, B. Thakuria9, A. Mahajan10, R. Singh11, A. Ghosh12, R. Handa13, Manjit Saluja14, A. Venugopalan1, V. Kunjeer1, B. Paul6, S. Pal7, K. Wangjam11, T. Kumar15 and K. Mahendranath16, 1Rheumatology, Center for Rheumatic Diseases, Pune, India, 2Center for Rheumatic Diseases, Pune, India, 3BJMC, Pune, India, 4Government Medical College Hospital, Trivandrum, India, 5SP Medical College, Bikaner, India, 6Calicut Medical College, Calicut, India, 7Advance Rheumatology Clinic, Hyderabad, India, 8FRCH, Pune, India, 9Guwahati Medical College & Hospital, Guwahati, India, 10Government Medical College, Jammu, India, 11Regional Institute of Medical Sciences, Imphal, Manipur, India, 12Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India, 13Department of Rheumatology, AIIMS, New Delhi, India, 14Clinical care, Center for Rheumatic Diseases, Pune, India, 15Institute of Post Graduate Medical Education and Research, Kolkata, India, 16Rheumatology Clinic, Bangalore, India

    Background/Purpose : The 1 % prevalence of RA Worldwide is a deep rooted ancient dogma. None of the recent WHO ILAR COPCORD (Community Oriented Program…
  • Abstract Number: 59 • 2012 ACR/ARHP Annual Meeting

    A Staggering Burden of Pain and Rheumatic Disorders in India: A National Bone & Joint Decade India Community Oriented Program for Control of Rheumatic Disease Survey 2006-2011

    Arvind Chopra1, R. Ghorpade1, S. Sarmukkadam2, VL Joshi1, AJ. Mathews3, L. Gauri4, A. Rahim5, K. Datta6, S. Chaturvedi7, B. Thakuria8, A. Mahajan9, R. Singh10, A. Ghosh11, R. Handa12, Manjit Saluja13, A. Venugopalan14, V. Kunjeer14, B. Paul5, S. Pal6, K. Wangjam10, T. Kumar15, CP Rajendran16, V. Gajalakshmi17 and K. Mahendranath18, 1Rheumatology, Center for Rheumatic Diseases, Pune, India, 2Biostatistics, B J Medical College, Pune, India, 3Government Medical College Hospital, Trivandrum, India, 4SP Medical College, Bikaner, India, 5Calicut Medical College, Calicut, India, 6Advance Rheumatology Clinic, Hyderabad, India, 7FRCH, Pune, India, 8Guwahati Medical College & Hospital, Guwahati, India, 9Government Medical College, Jammu, India, 10Regional Institute of Medical Sciences, Imphal, Manipur, India, 11Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India, 12Department of Rheumatology, AIIMS, New Delhi, India, 13Clinical care, Center for Rheumatic Diseases, Pune, India, 14Center for Rheumatic Diseases, Pune, India, 15Institute of Post Graduate Medical Education and Research, Kolkata, India, 16Madras Medical College, Chennai, India, 17ERC Unit, Chennai, India, 18Rheumatology clinic, Bangalore, India

    Background/Purpose : The maiden COPCORD (Community Oriented Program for Control of Rheumatic Diseases) population survey in village Bhigwan (Pune) findings proposed a high burden of…
  • Abstract Number: 60 • 2012 ACR/ARHP Annual Meeting

    The Burden of Early Arthritis in Latin America: Utility Analysis Using Patient-Level Data From the Argentinian Consortium for Early Arthritis

    Christian A. Waimann1, Gustavo Citera2, Hernan Maldonado Ficco3, Oscar L. Rillo4, Mariana Benegas5, Rafael Chaparro del Moral6, Antonio Catalan Pellet7, Anastasia Secco8, Lucila Marino9, Alberto Berman10, Horacio Berman10, Ana Lucía Barbaglia11, Juan Carlos Marcos12, Josefina Marcos13, Francisco Caeiro14, Maria Haye Salinas15, Ana C. Alvarez16, Enrique Soriano17, Zaida Bedran18, Sergio Paira19, Federico Ceccato19, Gabriela Salvatierra20, Ana Quinteros21, Emilio Buschiazzo22 and Edson Javier Velozo23, 1Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 3Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, 4Rheumatology, Hospital General de Agudos "Dr. E. Tornú", Buenos Aires, Argentina, 5Rheumatology, Hospital Tornu, Buenos Aires, Argentina, 6Rheumatology Section, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 7Rheumatology, Hospital Rivadavia, Buenos Aires, Argentina, 8Rheumathology, Hospital Bernardino Rivadavia, Buenos aires, Argentina, 9Rheumathology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 10Centro Medico Privado de Reumatologia, Tucuman, Argentina, 11Rheumatology, Hospital Padilla, Tucuman, Argentina, 12Rheumatology, Hospital San Martin, La Plata, Argentina, 13Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina, 14Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 15Reumatología, Hospital Privado de Córdoba, Córdoba, Argentina, 16Rheumatology, Hospital Privado, Córdoba, Argentina, 17Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 18Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 19Rheumatology, Hospital Jose Maria Cullen, Santa Fe, Argentina, 20Rheumatology, Centro de enfermedades Reumaticas, Santiago Del Estero, Argentina, 21Centro Integral de Reumatología, Tucumán, Argentina, 22Rheumatology, Hospital Señor del Milagro, Salta, Argentina, 23Rheumatology, Sanatorio Adventista del Plata, Entre Rios, Argentina

    Background/Purpose: Rheumatoid arthritis (RA) is estimated to be one of the leading causes of non-fatal burden in the world. However, data from developing countries including…
  • Abstract Number: 61 • 2012 ACR/ARHP Annual Meeting

    Role of Health Literacy in Population Estimates of Musculoskeletal Disorders

    Catherine L. Hill1, Sarah L. Appleton2, Tiffany K. Gill3, Julie Black4, Rima E. Rudd5 and Robert J. Adams6, 1Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia, 2Medicine, University of Adelaide, Woodville South, South Australia, Australia, 3The Health Observatory, University of Adelaide, Adelaide, South Australia, Australia, 4Arthritis SA, Marleston, Australia, 5Department of Society, Human Development, and Health, Harvard School of Public Health, Boston, MA, 6The Health Observatory, University of Adelaide, Woodville South, South Australia, Australia

    Background/Purpose: Disease diagnosis carries with it implications for self care and for healthful action. Public health campaigns, for example, are regularly launched to raise awareness…
  • Abstract Number: 62 • 2012 ACR/ARHP Annual Meeting

    Clinical Implication of Rheumatoid Factor Formation According to Various Hepatitis B Virus Infection Status and Vaccination

    Sang Tae Choi1, Hyun Woong Lee2, Jung-Soo Song1, Soo Kon Lee3 and Yong-Beom Park4, 1Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, 2Hepatology, Chung-Ang University School of Medicine, Seoul, South Korea, 3Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

    Background/Purpose: Rheumatoid factor (RF) is produced as a result of polyclonal B cell activation, but the reasons for its production are still unknown. RF positivity…
  • Abstract Number: 63 • 2012 ACR/ARHP Annual Meeting

    The Association Between Silica and the Risk of Anti-Citrullinated Protein Antibody Positive RA in the Malaysian and Swedish Epidemiological Investigation of Rheumatoid Arthritis Studies

    Abqariyah Yahya1, Camilla Bengtsson1, Lars Klareskog2, Chun Lai Too3, Shahnaz Murad4 and Lars Alfredsson1, 1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden, 3Karolinska Institutet, Stockholm, Sweden, 4Institute for Medical Research, Kuala Lumpur, Kuala Lumpur, Malaysia

    Background/Purpose: Silica exposure has been associated with an increased risk of developing ACPA+ (anti-citrullinated protein antibody) RA, especially among smokers (1). These findings were based…
  • « Previous Page
  • 1
  • …
  • 2597
  • 2598
  • 2599
  • 2600
  • 2601
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology